Aclarion, Inc. (NASDAQ:ACON) Short Interest Update

Aclarion, Inc. (NASDAQ:ACON) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 247,100 shares, an increase of 1,730.4% from the January 31st total of 13,500 shares. Based on an average daily trading volume, of 378,900 shares, the days-to-cover ratio is presently 0.7 days.

Aclarion Trading Down 2.3 %

NASDAQ ACON traded down $0.08 during trading hours on Thursday, hitting $3.22. The company’s stock had a trading volume of 101,582 shares, compared to its average volume of 648,956. The stock has a fifty day moving average of $17.17 and a 200 day moving average of $46.32. Aclarion has a twelve month low of $3.03 and a twelve month high of $231.15.

Analyst Ratings Changes

ACON has been the subject of several research reports. Ascendiant Capital Markets lowered their target price on Aclarion from $502.50 to $435.50 and set a “buy” rating for the company in a research note on Wednesday, November 27th. Maxim Group reiterated a “hold” rating on shares of Aclarion in a research report on Friday, December 13th.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.